20-minute flu test could save NHS up to £24m a year and free up beds, manufacturer says
Cobas Liat test can diagnose patient in just 20 minutes, but Public Health England warns there is no 'robust data' on effectiveness of new technology in NHS
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A test that can diagnose the flu in just 20 minutes has helped cut the numbers of needless admissions and freed up hospital beds in pilots at two NHS trusts.
Hospital patients usually have to wait for their tests to be sent to a laboratory and it can take several days to get the results, often meaning they are put into unnecessary isolation, significantly affecting the management of beds.
The new test - named cobas Liat - means medical staff who are worried about a patient's symptoms can take a single throat swab which is analysed by a machine.
Manufacturer Roche Diagnostics, an arm of the pharmaceutical giant, said the test could net the NHS savings of as much as £24m a year if rolled out across England.
However, infectious disease specialists at Public Health England said there were a number of tests coming on to the market, and while some early adopter trusts had found benefits there had yet to be a national assessment of their cost effectiveness.
Roche said it can be used to detect more than 40 strains of Influenza A and B, and seven of respiratory syncytial virus (RSV), a leading cause of respiratory disease.
Infectious disease specialists at Public Health England said there were a number of tests coming on to the market, and while some early adopter trusts had found benefits there had yet to be a national assessment of their cost effectiveness.
Norfolk and Norwich University Hospitals NHS Foundation Trust started using cobas Liat in January.
It found that out of 277 tests carried out after four months, 128 (46 per cent) came back positive, leading to more efficient use of side rooms and quicker diagnosis.
The number of blocked beds dropped from an average of 11 pre-test to two post-test, and the mean number of patients with flu in a bay dropped from 12.3 to 2.7 during the period.
The trust estimates the amount of money it could save over a flu season by using the test is around £142,555, before the cost of the kits is accounted for.
This includes £104,125 of bed days saved, £7,560 in blocked beds saved and £30,870 in avoided admissions.
The cobas Liat system has also been introduced in the emergency department and the acute assessment unit at Kingston Hospital NHS Foundation Trust in London.
Kingston is situated in a high elderly care catchment area, so the impact of the flu season can be severe.
The trust implemented the test after a large number of patients required unnecessary isolation during the 2016/17 flu season.
It carried out 1,526 tests over a 19-week period and found just 479 came back positive, with 65 per cent of suspected cases discharged or, if admitted, not requiring initial isolation once other risks had been ruled out.
The fast diagnosis meant 33 per cent of patients who tested negative and were otherwise well were discharged on the same day, avoiding unnecessary admissions.
Flu affects 5-10 per cent of adults and 20-30 per cent of children each year, peaking between January and March, while last winter saw a particularly challenging flu season.
Geoff Twist, managing director of Roche Diagnostics, said: “I am delighted that the cobas Liat test has received such good feedback from Kingston and Norfolk, with it leading to clear and significant reductions in the number of unnecessary admissions, blocked beds and bay closures.
“I am particularly happy that this helps us quickly relieve the stress for people of not knowing whether themselves or a loved one has the flu, and swiftly enabling their medical care.
“These tests not only help healthcare professionals make quick and effective decisions over the high pressure season and lead to long-term cost savings, but they give patients a better experience.”
Berenice Constable, head of nursing at Kingston Hospital NHS Foundation Trust, said: “This has had a big impact on improving timely treatment for patients, supporting appropriate isolation procedures and ultimately improving patient experience.
“Operationally it has helped to ensure that beds are not closed unnecessarily and has supported clinical decision making.”
Dr Maria Zambon, director of reference microbiology at Public Health England, said: “There are several rapid influenza diagnostic test devices coming onto the market place, and there is some early adopter experience in the UK.
"Robust data on the cost effectiveness of such devices in the NHS is lacking, although several early adopters have found them to be helpful in managing winter pressures.
"PHE does not endorse or recommend any individual device.”
Additional reporting by PA
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments